External Validation of Plasma Glycosaminoglycans as Biomarkers to Improve Lung Cancer Risk Stratification

Authors

Institutions

Publication Details

Journal
Cancer Epidemiology Biomarkers & Prevention
Published
2025-04-17
DOI
https://doi.org/10.1158/1055-9965.epi-24-1537
Primary Topic
Lung Cancer Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

External Validation of Plasma Glycosaminoglycans as Biomarkers to Improve Lung Cancer Risk Stratification

Francesco Gatto, John K. Field, Michael P.A. Davies
Cancer Epidemiology Biomarkers & Prevention
Lung Cancer Diagnosis and Treatment
article

External Validation of Plasma Glycosaminoglycans as Biomarkers to Improve Lung Cancer Risk Stratification

Francesco Gatto, John K. Field, Michael P.A. Davies
article en

Abstract

No abstract available for this paper.
Cancer Epidemiology Biomarkers & PreventionVol. 34(7)
University of Liverpool (GB), Lund University (SE), Karolinska Institutet (SE), Oncopeptides (Sweden) (SE)
Reduced inequalities
Openalex Percentile: Top 88%
Lung Cancer Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.